Luliclinz-XL Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections such as dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exhibits potent antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation allows for targeted delivery to affected skin areas, promoting rapid relief of symptoms including itching, redness, and scaling. Luliclinz-XL Cream is typically applied once daily to the affected area after cleansing and drying the skin, with treatment duration varying from one to four weeks depending on the infection type and severity. It is well-tolerated with minimal systemic absorption, reducing the risk of systemic side effects. Common local adverse reactions may include mild burning, irritation, or erythema at the application site, which are generally transient. Luliclinz-XL Cream should be used with caution in patients with known hypersensitivity to luliconazole or other imidazole antifungals. It is not recommended for use on mucous membranes or in systemic fungal infections. Proper adherence to prescribed treatment duration is essential to prevent recurrence and resistance.